When medicine is the conversation to have
On this page
If you already take a cholesterol medicine, your prescriber sets your goal and any change, so keep taking it and bring your questions to them. For everyone else, the 2026 US guideline turns to medicine at a few clear lines: heart disease, an LDL of 190 mg/dL or more, diabetes from age 40, and a 10-year risk of 5% or more after a talk with your doctor.
This guide helps you understand your numbers, do what you can with food, movement and habits, and walk into your doctor’s office knowing your options. It isn’t medical advice. If you want to start the natural way, see how to lower your cholesterol naturally. For both sides of the statin question, see the case for and against, and for whether food could be enough, can I manage it with lifestyle?
What we’d do
Find out whether you sit on one of the lines below. If you do, have the conversation now rather than after six months of trying food alone, and do the food changes as well, since they add to whatever a medicine does. Bring your last two panels, your family history and a list of everything you take. If you take a statin and something feels wrong, call the person who prescribed it before you change anything, because stopping raises your risk of a heart attack or stroke.
If you remember three things
- Food and medicine work together. Food takes off points. A statin takes off a percentage, 30% to 50% or more.
- A big gap is a medicine conversation. If you’re 40 or more points from your goal, food alone rarely closes it.
- Never stop a statin on your own. In blinded trials, most aches blamed on statins happened just as often on a sugar pill.
Why people put off the conversation
Plenty of people would rather try food first, and some feel that needing a pill means they failed. Others have heard that statins cause muscle pain in most people who take them, or that once you start you can never stop, so they wait for the next test, then the one after.
The waiting has a cost the guideline now spells out: the damage builds with every year LDL stays high (why LDL is a lifetime number). And the side effect fears come mostly from studies where people knew they were taking a statin. When nobody knew, the picture looked very different.
Like walking or driving
You’d walk to a store a few blocks away and drive to one across town. Food changes are the walk. Each one takes 7 to 13 points off LDL, and a few together can take off more. If your LDL is 115 and your goal is under 100, walking gets you there. If it’s 144 and your goal after a stent is under 55, that’s 89 points, and you need the car too. A statin takes off 30% to 50% or more.
The lines where the guideline turns to medicine
| Who | What the 2026 guideline says |
|---|---|
| You’ve had a heart attack, stroke, stent or bypass | A high-intensity statin for most people up to 75, with other medicines added to reach a goal under 55 (or under 70) |
| Your LDL is 190 or more | Look for causes and FH, and treat with the strongest statin you can take |
| You have diabetes and you’re 40 to 75 | A moderate statin, whatever your LDL. High intensity if you have several other risk factors |
| Your 10-year risk is 10% or more | A high-intensity statin is recommended if you start one |
| Your 10-year risk is 5 to under 10% | At least a moderate statin is recommended |
| Your 10-year risk is 3 to under 5% | A moderate statin is reasonable after a talk with your doctor, especially with risk enhancers like a family history |
| Your risk is low but your LDL is 160 to 189, at 30 to 59 | A moderate statin is reasonable, to cut the years of exposure |
| A coronary calcium score of 1,000 or more | Medicine aiming for at least a 50% drop and a goal under 55 |
| Chronic kidney disease stage 3 or 4, or HIV, at 40 to 75 | Cholesterol-lowering medicine whatever your LDL |
Your doctor works out your 10-year risk with the PREVENT equations, which use your age, sex, blood pressure, cholesterol, kidney function, diabetes and smoking (what should my LDL be?). We never calculate it on this site.
What statins do
Statins slow the liver’s own cholesterol making. A liver cell that’s short of cholesterol builds more LDL receptors and pulls more LDL from the blood. The 1985 Nobel Prize announcement for Michael Brown and Joseph Goldstein noted that one of the first statins, mevinolin, had raised receptor numbers in people with the milder form of FH (how it works).
| Statin intensity | How much it lowers LDL |
|---|---|
| Moderate | 30% to 49% |
| High | 50% or more |
At an LDL of 160, that’s about 48 to 78 points off with a moderate statin and 80 or more with a high one. In 26 trials with about 170,000 people, each 39 mg/dL (1 mmol/L) taken off cut heart attacks, strokes and artery procedures by about a fifth, and deaths from any cause by 10%. If a statin alone doesn’t reach the goal, the guideline lists other medicines a doctor can add: ezetimibe, which blocks cholesterol absorption in the gut, PCSK9 antibodies, which protect the liver’s receptors, and bempedoic acid and inclisiran.
For scale, the best food result we know, a month of the portfolio diet, lowered LDL 28.6% against 30.9% for a starter statin in the same trial. Six popular supplements, red yeast rice and plant sterol pills among them, did no better than a sugar pill in 28 days, while a 5 mg statin lowered LDL 35%.
What blinded trials found about side effects
In 2022 the Cholesterol Treatment Trialists pooled 19 double-blind trials of a statin against a placebo, with 123,940 people followed for about four years. Neither the people nor their doctors knew who was taking what.
- Muscle pain was common in both groups. 27.1% of people on a statin reported muscle pain or weakness, and 26.6% of people on placebo did.
- The statin added a little, early on. In the first year, the statin raised reports by 7%, about 11 extra people per 1,000 a year. After the first year there was no difference.
- Most aches weren’t the statin. The researchers worked out that more than 90% of the muscle complaints from people on a statin weren’t caused by it.
The guideline lists who is more likely to get real muscle symptoms: people on higher doses, those 65 and older, people with low body weight, women, people with an underactive thyroid, people who drink alcohol, people doing hard exercise and people on certain other medicines. It also says the most common serious side effect is new diabetes, since a statin can tip someone who already has prediabetes over the line, more so at high doses. The guideline says the people this happens to almost always had prediabetes already, and it still recommends continuing the statin in people who develop diabetes.
If you get aches on a statin, the guideline asks your clinician to take them seriously, to explain the higher heart and stroke risk that comes with stopping, and to offer other options. That conversation happens with your prescriber, before any change.
Why you never stop one on your own
Stopping a statin lets your LDL climb back and takes away the protection it was giving. In older adults who stopped statins they were taking to prevent a first heart attack, observational data found more heart attacks and strokes over five years. Your prescriber has other options, such as a lower dose, a different statin or a different medicine, and each of them keeps you protected while you sort out the problem. If you’re planning a pregnancy or find out you’re pregnant while on a statin, call your prescriber that week, since the guideline has specific advice for it.
What to bring to the visit
- Your last two or three panels, with dates and whether you fasted.
- Your family history. Who had a heart attack or stroke, and at what age.
- Everything you take, including supplements, since some interact with statins.
- Your questions. Which risk band am I in? What’s my LDL goal? Should I test Lp(a)? Would a calcium scan change the plan? When do we retest?
Chest pain, chest pressure, or sudden shortness of breath isn’t a cholesterol question. Call 911.
If you take a cholesterol medicine, your prescriber sets your goal and decides any start, stop or change. Keep taking it, and bring your questions to them.
6 sources
- Blumenthal RS, Morris PB, Gaudino M and others, 2026 ACC/AHA guideline on the management of dyslipidemia, JACC and Circulation, 13 March 2026doi.org
- Cholesterol Treatment Trialists' Collaboration, Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, Lancet, 2022pubmed.ncbi.nlm.nih.gov
- Cholesterol Treatment Trialists' Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 2010pubmed.ncbi.nlm.nih.gov
- The Nobel Assembly at the Karolinska Institute, The Nobel Prize in Physiology or Medicine 1985, press releasenobelprize.org
- Laffin LJ and others, Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers (SPORT), JACC, 2023pubmed.ncbi.nlm.nih.gov
- Jenkins DJ and others, Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein, JAMA, 2003pubmed.ncbi.nlm.nih.gov